TCL Archive Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned. November 5, 2004
TCL Archive Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse October 11, 2013
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
